Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit-Reference-Cited by-同舟云学术

Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit

Published:2013-09-03 Issue:12 Volume:28 Page:1675-1682
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Eskow Jaunarajs Karen L.¹,Standaert David G.¹,Viegas Tacey X.²,Bentley Michael D.²,Fang Zhihao²,Dizman Bekir²,Yoon Kunsang²,Weimer Rebecca²,Ravenscroft Paula³,Johnston Tom H.³,Hill Michael P.³,Brotchie Jonathan M.³,Moreadith Randall W.²

Affiliation:

1. Center for Neurodegeneration and Experimental Therapeutics, Department of NeurologyUniversity of Alabama‐BirminghamBirmingham Alabama USA

2. Serina Therapeutics, Inc.Huntsville Alabama USA

3. Atuka Ltd.Toronto Ontario Canada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.25625

Reference32 articles.

1. Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations

2. Continuous dopaminergic stimulation and novel formulations of dopamine agonists

3. REVIEW

4. Avoidance of dyskinesia: Preclinical evidence for continuous dopaminergic stimulation

5. Dopamine-receptor stimulation: biobehavioral and biochemical consequences

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments in synthetic approaches for macromolecular prodrugs;Progress in Polymer Science;2024-08

2. Polymer–drug and polymer–protein conjugated nanocarriers: Design, drug delivery, imaging, therapy, and clinical applications;WIREs Nanomedicine and Nanobiotechnology;2024-07

3. Substituting Poly(ethylene glycol) Lipids with Poly(2‐ethyl‐2‐oxazoline) Lipids Improves Lipid Nanoparticle Repeat Dosing;Advanced Healthcare Materials;2024-03-10

4. Novel and experimental therapeutics for the management of motor and non-motor Parkinsonian symptoms;Neurological Sciences;2024-02-23

5. A Novel PEtOx‐Based Nanogel Targeting Prostate Cancer Cells for Drug Delivery;Macromolecular Bioscience;2023-10-22